Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Other Liabilities Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Other Liabilities
kr508m
CAGR 3-Years
1%
CAGR 5-Years
172%
CAGR 10-Years
11%
Zealand Pharma A/S
CSE:ZEAL
Other Liabilities
kr142.2m
CAGR 3-Years
63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Other Liabilities
€1.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Other Liabilities
kr77.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
18%
F
Fluoguide AS
STO:FLUO
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genmab A/S's Other Liabilities?
Other Liabilities
508m DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Other Liabilities amounts to 508m DKK.

What is Genmab A/S's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
11%

Over the last year, the Other Liabilities growth was 0%. The average annual Other Liabilities growth rates for Genmab A/S have been 1% over the past three years , 172% over the past five years , and 11% over the past ten years .

Back to Top